MyFinsight
Home
Blog
About
Back
Cash Flow
Tvardi Therapeutics, Inc. (TVRD)
Tvardi Therapeutics, Inc. (TVRD)
source: myfinsight.com
Maturities of short-term
investments
$5,142K
(-53.48%↓ Y/Y)
Net cash provided by
(used in) investing...
$5,142K
(125.17%↑ Y/Y)
Net decrease in cash
and cash...
-$4,086K
(62.74%↑ Y/Y)
Canceled cashflow
$5,142K
Stock-based compensation
expense
$335K
(-52.62%↓ Y/Y)
Depreciation and
amortization expense
$23K
(-51.06%↓ Y/Y)
Non-cash lease expense
$20K
(-42.86%↓ Y/Y)
Net cash used in
operating activities
-$9,228K
(31.93%↑ Y/Y)
Canceled cashflow
$378K
Net loss
-$6,457K
(-19.31%↓ Y/Y)
Accounts payable and
accrued expenses
-$2,149K
(-1728.03%↓ Y/Y)
Prepaid expenses and
other assets
$958K
(-44.21%↓ Y/Y)
Operating lease
liabilities
-$28K
(42.86%↑ Y/Y)
Accretion of net discounts
on short-term...
$14K
(-90.07%↓ Y/Y)
Back